No profile data available.
iSpecimen Inc. (ISPC) is a healthcare company in the biological analysis equipment industry, based in Woburn, United States, with about 7 full-time employees.
It reported revenue of $1.93 million for fiscal year 2025, down 79.2% from fiscal year 2024, and net income of -$10.49 million. Americas was its largest region in fiscal year 2025, with 95% of revenue. Its market capitalization was $2.85 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
iSpecimen reported $1.93 million in revenue for fiscal year 2025, down 79.2% from $9.29 million in fiscal year 2024.
Americas: 95% of revenue by region in fiscal year 2025, followed by Europe, Middle East, and Africa (3%).
$2.85 million as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Rapid Micro Biosystems, Inc. (RPID), Bionano Genomics, Inc. (BNGO), Advanced Biomed Inc. (ADVB), International Stem Cell Corporation (ISCO).